Cargando…

Preventing Cardiotoxicity in Personalized Breast Irradiation

SIMPLE SUMMARY: Adjuvant radiotherapy is a standard of care in the treatment of breast cancer patients after surgery, but irradiation of left-sided breast cancer showed a higher incidence of adverse cardiac effects, mainly for left descending artery (LAD) irradiation. The aim of the study was to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Ippolito, Edy, Greco, Carlo, Marrocco, Maristella, Rinaldi, Carla Germana, Fiore, Michele, Trodella, Luca Eolo, D’Angelillo, Rolando Maria, Ramella, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650895/
https://www.ncbi.nlm.nih.gov/pubmed/37958327
http://dx.doi.org/10.3390/cancers15215153
_version_ 1785135886720040960
author Ippolito, Edy
Greco, Carlo
Marrocco, Maristella
Rinaldi, Carla Germana
Fiore, Michele
Trodella, Luca Eolo
D’Angelillo, Rolando Maria
Ramella, Sara
author_facet Ippolito, Edy
Greco, Carlo
Marrocco, Maristella
Rinaldi, Carla Germana
Fiore, Michele
Trodella, Luca Eolo
D’Angelillo, Rolando Maria
Ramella, Sara
author_sort Ippolito, Edy
collection PubMed
description SIMPLE SUMMARY: Adjuvant radiotherapy is a standard of care in the treatment of breast cancer patients after surgery, but irradiation of left-sided breast cancer showed a higher incidence of adverse cardiac effects, mainly for left descending artery (LAD) irradiation. The aim of the study was to assess the benefit of a deep inspiration breath hold (DIBH) over a standard irradiation technique. Patients received both standard and DIBH simulation. Data on 394 treatment plans (197 patients) were extracted and analyzed. The LAD dose was significantly reduced in DIBH plans with the maximum and mean dose reduced by 31.7% (mean value 3.5 Gy vs. 4.8 Gy, p ≤ 0.001) and 28.1% (mean value 8.2 Gy vs. 12.8 Gy, p ≤ 0.001) in DIBH plans compared to FB plans, underlying that patients could suffer less from irradiation cardiotoxicity with this technique. ABSTRACT: Background: This study aims to assess the benefit of a deep inspiration breath hold (DIBH) over the standard irradiation technique, and eventually to identify anatomical and/or treatment preplanning characteristics correlated with the LAD dose. Methods: Patients with left-sided breast cancer undergoing whole breast radiotherapy with DIBH were analyzed. All patients included in the analysis had plans in DIBH and free-breathing (FB). Receiving operating characteristics (ROC analysis) were used to identify the cut-off point of parameters to predict the LAD maximum dose > 10 Gy and LAD mean dose > 4 Gy, and the areas under the curve (AUCs) were computed. Post-test probability has been performed to evaluate the effect of parameters’ combination. Results: One hundred ninety-seven patients were analyzed. The LAD dose was significantly reduced in DIBH plans with the maximum and mean dose reduced by 31.7% (mean value 3.5 Gy vs. 4.8 Gy, p ≤ 0.001) and 28.1% (mean value 8.2 Gy vs. 12.8 Gy, p ≤ 0.001) in DIBH plans compared to FB plans. The strongest predictor of the LAD dose (maximum > 10 Gy and mean > 4 Gy) was the minimum distance of LAD from tangent open fields. Other parameters were lung volume and heart volume (LAD Dmax > 10 Gy) and lung volume, heart volume, and breast separation (LAD Dmean > 4 Gy). Conclusion: The dosimetric advantage of DIBH is clear in all patients and DIBH should always be preferred.
format Online
Article
Text
id pubmed-10650895
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106508952023-10-26 Preventing Cardiotoxicity in Personalized Breast Irradiation Ippolito, Edy Greco, Carlo Marrocco, Maristella Rinaldi, Carla Germana Fiore, Michele Trodella, Luca Eolo D’Angelillo, Rolando Maria Ramella, Sara Cancers (Basel) Article SIMPLE SUMMARY: Adjuvant radiotherapy is a standard of care in the treatment of breast cancer patients after surgery, but irradiation of left-sided breast cancer showed a higher incidence of adverse cardiac effects, mainly for left descending artery (LAD) irradiation. The aim of the study was to assess the benefit of a deep inspiration breath hold (DIBH) over a standard irradiation technique. Patients received both standard and DIBH simulation. Data on 394 treatment plans (197 patients) were extracted and analyzed. The LAD dose was significantly reduced in DIBH plans with the maximum and mean dose reduced by 31.7% (mean value 3.5 Gy vs. 4.8 Gy, p ≤ 0.001) and 28.1% (mean value 8.2 Gy vs. 12.8 Gy, p ≤ 0.001) in DIBH plans compared to FB plans, underlying that patients could suffer less from irradiation cardiotoxicity with this technique. ABSTRACT: Background: This study aims to assess the benefit of a deep inspiration breath hold (DIBH) over the standard irradiation technique, and eventually to identify anatomical and/or treatment preplanning characteristics correlated with the LAD dose. Methods: Patients with left-sided breast cancer undergoing whole breast radiotherapy with DIBH were analyzed. All patients included in the analysis had plans in DIBH and free-breathing (FB). Receiving operating characteristics (ROC analysis) were used to identify the cut-off point of parameters to predict the LAD maximum dose > 10 Gy and LAD mean dose > 4 Gy, and the areas under the curve (AUCs) were computed. Post-test probability has been performed to evaluate the effect of parameters’ combination. Results: One hundred ninety-seven patients were analyzed. The LAD dose was significantly reduced in DIBH plans with the maximum and mean dose reduced by 31.7% (mean value 3.5 Gy vs. 4.8 Gy, p ≤ 0.001) and 28.1% (mean value 8.2 Gy vs. 12.8 Gy, p ≤ 0.001) in DIBH plans compared to FB plans. The strongest predictor of the LAD dose (maximum > 10 Gy and mean > 4 Gy) was the minimum distance of LAD from tangent open fields. Other parameters were lung volume and heart volume (LAD Dmax > 10 Gy) and lung volume, heart volume, and breast separation (LAD Dmean > 4 Gy). Conclusion: The dosimetric advantage of DIBH is clear in all patients and DIBH should always be preferred. MDPI 2023-10-26 /pmc/articles/PMC10650895/ /pubmed/37958327 http://dx.doi.org/10.3390/cancers15215153 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ippolito, Edy
Greco, Carlo
Marrocco, Maristella
Rinaldi, Carla Germana
Fiore, Michele
Trodella, Luca Eolo
D’Angelillo, Rolando Maria
Ramella, Sara
Preventing Cardiotoxicity in Personalized Breast Irradiation
title Preventing Cardiotoxicity in Personalized Breast Irradiation
title_full Preventing Cardiotoxicity in Personalized Breast Irradiation
title_fullStr Preventing Cardiotoxicity in Personalized Breast Irradiation
title_full_unstemmed Preventing Cardiotoxicity in Personalized Breast Irradiation
title_short Preventing Cardiotoxicity in Personalized Breast Irradiation
title_sort preventing cardiotoxicity in personalized breast irradiation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650895/
https://www.ncbi.nlm.nih.gov/pubmed/37958327
http://dx.doi.org/10.3390/cancers15215153
work_keys_str_mv AT ippolitoedy preventingcardiotoxicityinpersonalizedbreastirradiation
AT grecocarlo preventingcardiotoxicityinpersonalizedbreastirradiation
AT marroccomaristella preventingcardiotoxicityinpersonalizedbreastirradiation
AT rinaldicarlagermana preventingcardiotoxicityinpersonalizedbreastirradiation
AT fioremichele preventingcardiotoxicityinpersonalizedbreastirradiation
AT trodellalucaeolo preventingcardiotoxicityinpersonalizedbreastirradiation
AT dangelillorolandomaria preventingcardiotoxicityinpersonalizedbreastirradiation
AT ramellasara preventingcardiotoxicityinpersonalizedbreastirradiation